[Lingua villosa nigra after chemotherapy].
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.
Sihame
S
Lkhoyaali
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.
Hassan
H
Errihani
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D009918:Orbital Neoplasms / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D014064:Tongue, Hairy / Q000139:chemically induced* / Q000175:diagnosis; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
CHOP; Lingua villosa nigra; chimiotherapy